window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Artificial Intelligence,Drug Development,Partnerships & Funding,Technology and platforms

    Lilly launches $1 billion TuneLab AI platform to boost biotech drug discovery

    Eli Lilly and Company has launched TuneLab, a new artificial [...]

    September 10, 2025
  • Data Management,Regulatory Affairs,Technology and platforms

    More than 450 companies adopt Veeva RIM to accelerate regulatory submissions

    Veeva Systems announced today that more than 450 companies, including [...]

    September 8, 2025
  • Digital Health,Medical devices,Patient Centricity,Technology and platforms

    ViCentra raises $85M to scale manufacturing and accelerate market penetration of Kaleido insulin patch pump

    ViCentra, a European medical device company redefining insulin delivery for [...]

    September 8, 2025
  • Drug Development,RNA Therapeutics,Technology and platforms

    Hongene to supply exNA oligonucleotide technology under new licensing deal

    Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) [...]

    September 7, 2025
  • Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    Adva Biotechnology and Autolomous launch digital pioneer program for scalable autologous cell therapy manufacturing

    Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic [...]

    September 7, 2025
  • Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Technology and platforms

    SynGenSys launches NK.SET synthetic promoter library to support NK cell therapy development

    SynGenSys, a biotechnology company developing synthetic gene promoter systems, has [...]

    September 23, 2025
  • Genomics and sequencing,Research & Development,Technology and platforms

    Bio-Rad expands range of StarBright dyes to enhance panel design capabilities for spectral flow cytometry

    Bio-Rad Laboratories, a global provider of life science research and [...]

    August 27, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Patient Centricity,Technology and platforms

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    August 27, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Drug Delivery & Formulation,Technology and platforms

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    August 21, 2025
  • Cell & Gene Therapy,Medical devices,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    August 25, 2025
Previous141516Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PRISM ALS initiative develops patient-derived stem cell models to improve ALS/MND drug discovery
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Research & Development, Technology and platforms
  • Proxygen appoints Chiara Conti as chief scientific officer to support move into clinical-stage development
    Categories: Biotech, Drug discovery, Healthcare leadership, Movers & Shakers, Research & Development, Startups and innovations, Technology and platforms
  • Efzimfotase alfa shows mixed Phase 3 results in hypophosphatasia across pediatric and adult patients
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top